Exome sequencing reveals novel and recurrent mutations with clinical significance in inherited retinal dystrophies.

TitleExome sequencing reveals novel and recurrent mutations with clinical significance in inherited retinal dystrophies.
Publication TypeJournal Article
Year of Publication2014
Authorsdel Pozo, MGonzález-, Méndez-Vidal, C, Bravo-Gil, N, Vela-Boza, A, Dopazo, J, Borrego, S, Antiňolo, G
JournalPLoS One
Date Published2014
KeywordsAdolescent; Adult; Amino Acid Sequence; Base Sequence; Child; Chromosome Segregation; DNA Mutational Analysis; Exome; Family; Female; Humans; Inheritance Patterns; Male; Middle Aged; Molecular Sequence Data; mutation; Pedigree; Retinal Dystrophies; Rhodopsin

This study aimed to identify the underlying molecular genetic cause in four Spanish families clinically diagnosed of Retinitis Pigmentosa (RP), comprising one autosomal dominant RP (adRP), two autosomal recessive RP (arRP) and one with two possible modes of inheritance: arRP or X-Linked RP (XLRP). We performed whole exome sequencing (WES) using NimbleGen SeqCap EZ Exome V3 sample preparation kit and SOLID 5500xl platform. All variants passing filter criteria were validated by Sanger sequencing to confirm familial segregation and the absence in local control population. This strategy allowed the detection of: (i) one novel heterozygous splice-site deletion in RHO, c.937-2_944del, (ii) one rare homozygous mutation in C2orf71, c.1795T>C; p.Cys599Arg, not previously associated with the disease, (iii) two heterozygous null mutations in ABCA4, c.2041C>T; p.R681* and c.6088C>T; p.R2030*, and (iv) one mutation, c.2405-2406delAG; p.Glu802Glyfs*31 in the ORF15 of RPGR. The molecular findings for RHO and C2orf71 confirmed the initial diagnosis of adRP and arRP, respectively, while patients with the two ABCA4 mutations, both previously associated with Stargardt disease, presented symptoms of RP with early macular involvement. Finally, the X-Linked inheritance was confirmed for the family with the RPGR mutation. This latter finding allowed the inclusion of carrier sisters in our preimplantational genetic diagnosis program.

Alternate JournalPLoS One
PubMed ID25544989
PubMed Central IDPMC4278866